MSc Gabriela Baranowska Gabriela Baranowska

Doctoral // Gabriela Baranowska

Information:

 

  • Name:                     Gabriela Baranowska
  • E-mail address:         gabriela.anna.baranowska@gmail.com

 Education:

 2011 – 2013: Anacardic acid - antimicrobial activity and a potential cosmetic preservative

 The aim of this study was to determine the survival and MIC determination of selected bacterial strains in the presence of AA. This study also evaluated the potential of anacardic acid as a potential cosmetic preservative.

 Supervisior: Dr. Anna Jaromin

 

2010 – 2011: Self - Emulsifying Drug Delivery Systems

 Weak solubility of drugs is an essential and very often met problem of modern pharmacology. This occurrence is counteracted by substances created on the base of lipid compounds which help in absorption of drugs weakly dissolving in water in the gastrointestinal tract. There has been created self-emulsifying systems consisted of the mixture of oils, surfactant and co-surfactant.

 

Supervisior: Dr. Anna Jaromin

About:
Publications

Filter publications:  
Author Title Date  

  • Biosurfactants

    We identified chemical structures of newly isolated biosurfactants which are secreted by Arctic microorganisms. We are investigating their antibacterial, antifungal properties as well as proapoptotic activity. Biosurfactants can be used as an antiseptics.

  • Biogas

    We are investigating and optimizing the efficiency of metanogenesis in bioreactors. We are also testing various substrates (industrial waste) as materials for biogas production. Microorganisms which participate in this process are investigated as e.g. biofilm producers.

  • Bacteriophages

    Bacteriophages or phages are bacterial viruses. We isolated and are now investigating phages which kill Bacillus strains. Beside the basic research, the collection of phages can be used in industry as for example eliminators of infections.

  • Antiseptics

    Fungal infections are difficult to treat because of the small number of effective drugs. Candida albicans resistance depends on the activity of ABC transporters (MDR, CDR). We have investigated strains and methods for finding new antifungal compounds (synthetic and natural) e.g. probiotic yeast Saccharomyces boulardii.